Concepedia

Publication | Closed Access

Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

DOI

638

Citations

22

References

2015

Year

Camille Hua, Lise Boussemart, Christine Mateus, Émilie Routier, C. Boutros, H. Cazenave, R. Viollet, M. Thomas, Séverine Le Roy, Naima Benannoune,
JAMA Dermatology

Abstract

Vitiligo, a clinically visible immune-related adverse event could be associated with clinical benefit in the context of pembrolizumab treatment.

References

YearCitations

Page 1